Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Nib Holdings Limited (NHF.AX)
AUD7.27
-0.01 (-0.14%)
AU ASX Financial Services Insurance - Specialty
Address
22 Honeysuckle Drive 2300
Newcastle, NSW, AU
Newcastle, NSW, AU
CEO
Edward Close
Website
nib.com.au
IPO
2007-11-04
ISIN AU000000NHF0
Description
Nib Holdings Limited, through its various subsidiaries, underwrites and distributes private health insurance to a broad clientele, encompassing local residents, international students, and visitors in both Australia and New Zealand. Its business is conducted through distinct divisions: Australian Residents Health Insurance, New Zealand Insurance, International (Inbound) Health Insurance, and nib Travel. The firm's product offerings include various health insurance plans—catering to individuals, couples, single parents, and families—alongside travel insurance. Established in 1952, the company maintains its principal office in Newcastle, Australia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
AUD7.27
-0.01 (-0.14%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
999.4K
Beta
0.07
Float Shares
483.42M
Free Float %
99.1%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.62% | -1.76% | +0.45% | +4.21% | -6.83% | -2.62% | -3.05% | -20.95% | +6.20% | +44.90% | +466.10% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
7.27
DCF (Unlevered)
5.67
-22.0%
DCF (Levered)
15.23
+109.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
58% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 3 | 0 |
| Buy | 4 | 0 |
| Hold | 4 | +1 |
| Sell | 1 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.99
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
7 / 10
Strong MOAT
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Insurance - Specialty: +11.0%+4.3% Q4'25: +12.4% (vs Q4'23)
-
EPS growth Insurance - Specialty: +18.3%+7.9% Q4'25: -22.7% (vs Q4'23)
-
FCF margin FCF growth · Insurance - Specialty: +39.7%+4.7% Q4'25: -0.1% (vs Q4'23)
-
EBIT margin Insurance - Specialty: +18.3%+7.7% Q4'25: +6.6% (vs Q4'23)
-
ROIC Insurance - Specialty: +10.3%+20.5% ★ Q4'25: +28.2% (vs Q4'23)
-
Share dilution Insurance - Specialty: +0.5%+0.4% Q4'25: +0.8% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Specialty: 0.25×0.96× ★ Q4'25: 0.61× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2010 actual |
Jun 2011 actual |
Jun 2012 actual |
Jun 2013 actual |
Jun 2014 actual |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 5 Rev. Ana. 7 EPS Ana. |
Jun 2027 4 Rev. Ana. 7 EPS Ana. |
Jun 2028 4 Rev. Ana. 6 EPS Ana. |
Jun 2029 2 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
948.46M
est: 929.81M (+2.0%)
|
1.05B
est: 1.04B (+1.2%)
|
1.15B
est: 1.13B (+1.7%)
|
1.32B
est: 1.31B (+0.8%)
|
1.53B
est: 1.52B (+0.5%)
|
1.67B
est: 1.63B (+2.3%)
|
1.89B
est: 1.82B (+3.7%)
|
2.04B
est: 1.96B (+4.1%)
|
2.26B
est: 2.13B (+6.0%)
|
2.46B
est: 2.34B (+4.8%)
|
2.54B
est: 2.46B (+3.3%)
|
2.60B
est: 2.55B (+1.9%)
|
2.79B
est: 2.74B (+2.1%)
|
3.12B
est: 2.90B (+7.6%)
|
3.44B
est: 3.21B (+7.1%)
|
3.59B
est: 3.48B (+3.2%)
|
3.72B
3.67B – 3.80B
+6.9% YoY
|
3.98B
3.92B – 4.10B
+7.1% YoY
|
4.24B
4.22B – 4.25B
+6.4% YoY
|
4.38B
4.32B – 4.50B
+3.4% YoY
|
| EBITDA |
91.72M
est: 82.93M (+10.6%)
|
98.75M
est: 145.72M (-32.2%)
|
102.92M
est: 137.62M (-25.2%)
|
—
est: 141.03M (-100.0%)
|
113.88M
est: 145.02M (-21.5%)
|
125.59M
est: 108.56M (+15.7%)
|
156.10M
est: 122.77M (+27.1%)
|
201.20M
est: 143.43M (+40.3%)
|
223.50M
est: 189.41M (+18.0%)
|
246.50M
est: 211.20M (+16.7%)
|
169.90M
est: 221.75M (-23.4%)
|
274.80M
est: 126.29M (+117.6%)
|
236.80M
est: 131.42M (+80.2%)
|
220.60M
est: 138.11M (+59.7%)
|
324.50M
est: 144.48M (+124.6%)
|
324.60M
est: 310.64M (+4.5%)
|
331.50M
327.58M – 338.87M
+6.7% YoY
|
354.91M
349.34M – 365.79M
+7.1% YoY
|
377.79M
376.40M – 379.19M
+6.4% YoY
|
390.66M
385.26M – 401.04M
+3.4% YoY
|
| EBIT |
86.97M
est: 71.56M (+21.5%)
|
91.92M
est: 52.43M (+75.3%)
|
95.66M
est: 67.49M (+41.7%)
|
98.04M
est: 81.78M (+19.9%)
|
101.91M
est: 85.60M (+19.1%)
|
113.01M
est: 105.83M (+6.8%)
|
137.67M
est: 121.40M (+13.4%)
|
179.50M
est: 141.34M (+27.0%)
|
199.10M
est: 189.52M (+5.1%)
|
221.70M
est: 207.89M (+6.6%)
|
134.70M
est: 215.71M (-37.6%)
|
242.80M
est: 119.82M (+102.6%)
|
205.10M
est: 124.69M (+64.5%)
|
184.90M
est: 131.04M (+41.1%)
|
281.30M
est: 137.09M (+105.2%)
|
277.80M
est: 268.05M (+3.6%)
|
286.05M
282.66M – 292.41M
+6.7% YoY
|
306.25M
301.45M – 315.64M
+7.1% YoY
|
326.00M
324.79M – 327.20M
+6.4% YoY
|
337.09M
332.44M – 346.05M
+3.4% YoY
|
| Net Income |
61.53M
est: 64.16M (-4.1%)
|
65.46M
est: 68.46M (-4.4%)
|
67.64M
est: 71.88M (-5.9%)
|
67.16M
est: 78.08M (-14.0%)
|
69.91M
est: 77.84M (-10.2%)
|
75.80M
est: 76.42M (-0.8%)
|
92.85M
est: 84.50M (+9.9%)
|
119.60M
est: 99.80M (+19.8%)
|
132.40M
est: 130.34M (+1.6%)
|
149.30M
est: 146.25M (+2.1%)
|
89.20M
est: 155.44M (-42.6%)
|
160.50M
est: 90.12M (+78.1%)
|
133.80M
est: 93.78M (+42.7%)
|
191.10M
est: 197.60M (-3.3%)
|
185.60M
est: 186.60M (-0.5%)
|
199.80M
est: 195.50M (+2.2%)
|
203.39M
193.76M – 213.02M
+4.0% YoY
|
220.90M
209.44M – 239.33M
+8.6% YoY
|
233.18M
221.13M – 259.06M
+5.6% YoY
|
264.72M
259.97M – 273.87M
+13.5% YoY
|
| SGA |
59.85M
est: 52.7K (+113,366.9%)
|
—
est: 58.7K (-100.0%)
|
—
est: 64.4K (-100.0%)
|
95.62M
est: 74.4K (+128,439.0%)
|
—
est: 86.2K (-100.0%)
|
—
est: 92.6K (-100.0%)
|
209.19M
est: 103.4K (+202,280.9%)
|
244.80M
est: 111.1K (+220,339.3%)
|
284.30M
est: 121.0K (+234,775.2%)
|
—
est: 133.0K (-100.0%)
|
200.0K
est: 139.5K (+43.4%)
|
100.0K
est: 144.6K (-30.8%)
|
100.0K
est: 155.3K (-35.6%)
|
200.0K
est: 164.5K (+21.6%)
|
500.0K
est: 182.3K (+174.3%)
|
—
est: 197.3K (-100.0%)
|
210.8K
208.3K – 215.5K
+6.9% YoY
|
225.7K
222.2K – 232.7K
+7.1% YoY
|
240.3K
239.4K – 241.2K
+6.4% YoY
|
248.5K
245.0K – 255.1K
+3.4% YoY
|
| EPS |
0.12
est: 0.13 (-9.1%)
|
0.14
est: 0.13 (+8.1%)
|
0.15
est: 0.14 (+9.5%)
|
0.15
est: 0.16 (-5.0%)
|
0.16
est: 0.16 (-0.2%)
|
0.17
est: 0.16 (+4.0%)
|
0.21
est: 0.22 (-3.7%)
|
0.27
est: 0.27 (-0.9%)
|
0.29
est: 0.31 (-5.9%)
|
0.31
est: 0.34 (-8.9%)
|
0.19
est: 0.26 (-27.6%)
|
0.35
est: 0.35 (-0.6%)
|
0.30
est: 0.30 (+0.4%)
|
0.41
est: 0.41 (+0.3%)
|
0.38
est: 0.44 (-14.6%)
|
0.41
est: 0.41 (+1.1%)
|
0.42
0.40 – 0.44
+2.8% YoY
|
0.47
0.43 – 0.49
+12.2% YoY
|
0.50
0.45 – 0.53
+6.4% YoY
|
0.54
0.53 – 0.56
+9.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-01 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
327.84M
OE per share TTM
0.68
Owner's Yield
10.07%
Maintenance CapEx ratio
19.30%
Maint CapEx / Avg PPE
1.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
148.6K
Shares Outstanding
488.05M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Edward Close | MD, Chief Executive Officer & Executive Director | 2M | male |
| Nick Freeman | Group Chief Financial Officer | 1M | male |
| Rhoderic McKensey | Chief Executive Officer of nib Health Strategy & Services | 801.4K | male |
| James Barr | Chief Executive of Australian Private Health Insurance | 775.3K | male |
| Lauren Daniels | Group Chief People Officer | 714.5K | female |
| Dan Anderson | Head of Investor Relations | — | — |
| Skye Daniels | Chief Executive Officer nib New Zealand | — | female |
| Glenn Moore | Acting Group Chief Technology & Transformation Officer | — | male |
| Jessica Morrell | Acting Group Chief Risk Officer | — | female |
| Jordan French | General Counsel & Company Secretary | — | male |
| Renea Jaeger | Head of Corporate Relations | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NHF.AX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
